Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
Journal Article
Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016;164(5):1060-1072.
Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016;164(5):1060-1072.
Serin I, Pehlivan S, Demir I, Oyacı Y, Pehlivan M. A New Clock is Running for Multiple Myeloma: Circadian Clock Protein-Period 3 (PER-3) Polymorphism. Balkan J Med Genet. 2023;25(2):37-43.
Ji J, Liu Z, Kuang P, Dong T, Chen X, Li J, Zhang C, Liu J, Zhang L, Shen K, et al. A New Conditioning Regimen with Chidamide, Cladribine, Gemcitabine, and Busulfan Significantly Improve the Outcome of High-risk or Relapsed/Refractory non-Hodgkin's Lymphomas. Int J Cancer. 2021.
Zhang C, Zhu N, Li H, Gong Y, Gu J, Shi Y, Liao D, Wang W, Dai A, Qin L. New dawn for cancer cell death: Emerging role of lipid metabolism. Mol Metab. 2022:101529.
Dou S, Liu X, Shi W, Gao H. New dawn for keratoconus treatment: potential strategies for corneal stromal regeneration. Stem Cell Res Ther. 2023;14(1):317.
de Carvalho VSilva, Lima KMotta Melo, de Azevedo LFrança Ca, Neves PAlexandre, Borges RDos Santos, Nagamachi CYoshiko, Pieczarka JCesar. New derivative of trans-dehydrocrotonin isolated from Croton cajucara shows reduced cytotoxic and genotoxic effects in hepatocellular carcinoma (HepG2) cell line. Toxicon. 2022:106940.
de Carvalho VSilva, Lima KMotta Melo, de Azevedo LFrança Ca, Neves PAlexandre, Borges RDos Santos, Nagamachi CYoshiko, Pieczarka JCesar. New derivative of trans-dehydrocrotonin isolated from Croton cajucara shows reduced cytotoxic and genotoxic effects in hepatocellular carcinoma (HepG2) cell line. Toxicon. 2022:106940.
Kent RSalomon, Marom R, John S, Dundr M, Schiltz LR, Gutierrez J, Workman J, Benayahu D, Hager GL. New face for Chromatin-Related Mesenchymal Modulator: n-CHD9 localizes to nucleoli and interacts with ribosomal genes. J Cell Physiol. 2015.
Dotan M, Blau H, Singer A, Stafler P, Prais D, Cohen-Cymberknoh M, Reiter J, Efrati O, Dagan A, Bentur L, et al. The new face of cystic fibrosis in the era of population genetic carrier screening. J Cyst Fibros. 2023.
Dotan M, Blau H, Singer A, Stafler P, Prais D, Cohen-Cymberknoh M, Reiter J, Efrati O, Dagan A, Bentur L, et al. The new face of cystic fibrosis in the era of population genetic carrier screening. J Cyst Fibros. 2023.
Lazar N, Mesarich CH, Petit-Houdenot Y, Talbi N, de la Sierra-Gallay ILi, Zélie E, Blondeau K, Gracy J, Ollivier B, Blaise F, et al. A new family of structurally conserved fungal effectors displays epistatic interactions with plant resistance proteins. PLoS Pathog. 2022;18(7):e1010664.
Gonzalez JMartin, Baudet A, Abelechian S, Bonderup K, D'Altri T, Porse B, Brakebusch C, Juliusson G, Cammenga J. A new genetic tool to improve immune-compromised mouse models: Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines. Genesis. 2018.
Westbroek W, Nguyen M, Siebert M, Lindstrom T, Burnett RA, Aflaki E, Jung O, Tamargo R, Rodriguez-Gil JL, Acosta W, et al. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease. Dis Model Mech. 2016;9(7):769-778.
Tan JL, Li F, Yeo JZ, Yong KJia, Bassal MA, Ng GHao, Lee MYin, Leong CYan, Tan HKee, Wu C-S, et al. New High-throughput Screen Identifies Compounds That Reduce Viability Specifically In Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation. Gastroenterology. 2019.
Okoye-Okafor UC, Bartholdy B, Cartier J, Gao EN, Pietrak B, Rendina AR, Rominger C, Quinn C, Smallwood A, Wiggall KJ, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015.
Okoye-Okafor UC, Bartholdy B, Cartier J, Gao EN, Pietrak B, Rendina AR, Rominger C, Quinn C, Smallwood A, Wiggall KJ, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015.
Mukherjee I, Singh S, Karmakar A, Kashyap N, Mridha ARanjan, Sharma JBhagwan, Luthra K, Sharma RShyam, Biswas S, Dhar R, et al. "New immune horizons in therapeutics and diagnostic approaches to preeclampsia". Am J Reprod Immunol. 2022.
Li F, Liu Y, Ding Y, Xie Q. A new injectable in situ forming hydroxyapatite and thermosensitive chitosan gel promoted by Na₂CO₃. Soft Matter. 2014;10(13):2292-303.
Mahalaxmi I, Devi SMohana, Kaavya J, Arul S, Balachandar V, Santhy KSivanandan. New insight into NANOG: A novel therapeutic target for ovarian cancer (OC). Eur J Pharmacol. 2019.
Chapel A, Francois S, Douay L, Benderitter M, Voswinkel J. New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy. World J Stem Cells. 2013;5(4):106-11.
Minniti ME, Pedrelli M, Vedin L-L, Delbès A-S, Denis RGP, Öörni K, Sala C, Pirazzini C, Thiagarajan D, Nurmi HJ, et al. New insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans. Hepatology. 2019.
Minniti ME, Pedrelli M, Vedin L-L, Delbès A-S, Denis RGP, Öörni K, Sala C, Pirazzini C, Thiagarajan D, Nurmi HJ, et al. New insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans. Hepatology. 2019.
Zinter MS, Dvorak CC, Spicer A, Cowan MJ, Sapru A. New Insights Into Multicenter PICU Mortality Among Pediatric Hematopoietic Stem Cell Transplant Patients. Crit Care Med. 2015.
Elfeky R, Lucchini G, Lum S-H, Ottaviano G, Builes N, Nademi Z, Battersby A, Flood T, Owens S, Cant AJ, et al. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT. Blood Adv. 2020;4(11):2418-2429.

Pages